Literature DB >> 25567212

Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus.

S Kurečić Filipović1, I Gjenero-Margan2, E Kissling3, B Kaić1, A Cvitković4.   

Abstract

This is a retrospective study using the test-negative case-control method to estimate seasonal 2010-2011 influenza vaccine effectiveness (VE) in Croatia. Of patients consulting a physician for influenza-like illness (ILI) and for whom a swab was taken, we compared RT-PCR influenza-positive and RT-PCR influenza-negative patients. We used a structured questionnaire and physicians' records to obtain information on vaccination status and potential confounders. We conducted a complete case analysis using logistic regression to measure adjusted VE overall, against A(H1N1)pdm09 and in age groups. Out of 785 interviewed patients, 495 eligible patients were included in the study, after applying exclusion criteria [217 cases, of which 92·6% were A(H1N1)pdm09 positive, 278 controls]. Crude VE was 31·9% [95% confidence interval (CI) -40·9 to 67·1] and adjusted VE was 20·7% (95% CI -71·4 to 63·3), with higher VE in youngest and oldest age groups. Results from this first VE study in Croatia suggest a low to moderate VE for the 2010-2011 season. Studies year on year are needed with a greater sample size to provide more precise estimates, and also by age group and risk groups for vaccination.

Entities:  

Keywords:  Influenza; influenza vaccines; vaccination (immunization)

Mesh:

Substances:

Year:  2015        PMID: 25567212      PMCID: PMC9151050          DOI: 10.1017/S0950268814003677

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  15 in total

Review 1.  Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.

Authors:  E Hak; Th J M Verheij; D E Grobbee; K L Nichol; A W Hoes
Journal:  J Epidemiol Community Health       Date:  2002-12       Impact factor: 3.710

2.  Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks.

Authors:  Marta Valenciano; Esther Kissling; Bruno Christian Ciancio; Alain Moren
Journal:  Vaccine       Date:  2010-09-17       Impact factor: 3.641

3.  Influenza vaccine effectiveness, 2010/11.

Authors:  A Steens; W van der Hoek; F Dijkstra; M van der Sande
Journal:  Euro Surveill       Date:  2011-04-14

4.  Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis.

Authors:  J Castilla; J Moran; V Martinez-Artola; G Reina; I Martinez-Baz; M Garcia Cenoz; N Alvarez; F Irisarri; M Arriazu; F Elia; E Salcedo
Journal:  Euro Surveill       Date:  2011-02-17

5.  Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.

Authors:  S Jiménez-Jorge; C Savulescu; F Pozo; S de Mateo; I Casas; J Ledesma; A Larrauri
Journal:  Vaccine       Date:  2012-03-31       Impact factor: 3.641

6.  Field evaluation of vaccine efficacy.

Authors:  W A Orenstein; R H Bernier; T J Dondero; A R Hinman; J S Marks; K J Bart; B Sirotkin
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

7.  Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

Authors:  Evan W Orenstein; Gaston De Serres; Michael J Haber; David K Shay; Carolyn B Bridges; Paul Gargiullo; Walter A Orenstein
Journal:  Int J Epidemiol       Date:  2007-04-02       Impact factor: 7.196

8.  Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.

Authors:  R Pebody; P Hardelid; Dm Fleming; J McMenamin; N Andrews; C Robertson; Dr Thomas; P Sebastianpillai; J Ellis; W Carman; T Wreghitt; M Zambon; Jm Watson
Journal:  Euro Surveill       Date:  2011-02-10

9.  Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study.

Authors:  C Savulescu; S Jiménez-Jorge; S de Mateo; J Ledesma; F Pozo; I Casas; A Larrauri
Journal:  Euro Surveill       Date:  2011-03-17

10.  I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.

Authors:  Esther Kissling; Marta Valenciano; Jean Marie Cohen; Beatrix Oroszi; Anne-Sophie Barret; Caterina Rizzo; Pawel Stefanoff; Baltazar Nunes; Daniela Pitigoi; Amparo Larrauri; Isabelle Daviaud; Judit Krisztina Horvath; Joan O'Donnell; Thomas Seyler; Iwona Anna Paradowska-Stankiewicz; Pedro Pechirra; Alina Elena Ivanciuc; Silvia Jiménez-Jorge; Camelia Savulescu; Bruno Christian Ciancio; Alain Moren
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

View more
  2 in total

1.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

Review 2.  Variations in Seasonal Influenza Vaccine Effectiveness due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design Studies.

Authors:  George N Okoli; Florentin Racovitan; Christiaan H Righolt; Salaheddin M Mahmud
Journal:  Open Forum Infect Dis       Date:  2020-05-21       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.